VAPB and neuropathy: iNPCs carrying a neuropathy-related dominant GARS mutation showed reduced VAPB and its downstream pathways, including altered mitochondrial and cellular calcium homeostasis, providing a potential explanation for neuron-specific clinical manifestations (Fig. 8B).